Pyc Therapeutics Limited has released a press release.
PKD - Safety Committee Approves Dose Escalation
Earlier from Pyc Therapeutics
- ADOA Program Update
- PKD - Initiation of Multiple Dose Clinical Trial
- Presentation of Ophthalmology Clinical Trial Data at ARVO
- ADOA Program - SRC Approve Progression to Multi-Dose Study